In addition, Pan et al. applied donor-derived CD7 CAR T cells in a phase 1 trial for 20 r/r T-ALL patients (NCT04689659, ChiCTR2000034762) [82]. The gene discussed is CD7; the disease is acute lymphoblastic leukemia.